comparative trials , though few , indicate that the clinical and bacteriological efficacy of cefixime 200 to 400mg daily administered as a single dose or in 2 divided doses , is comparable with that of multiple daily doses of co-trimoxazole ( trimethoprim + sulphamethoxazole ) or amoxycillin in acute uncomplicated urinary tract infection , with that of amoxycillin , amoxycillin/clavulanic acid and cefaclor in acute lower respiratory tract infections , and with that of amoxycillin and cefroxidine in adult patients with acute tonsillitis or pharyngitis .
C0007537
cefaclor
C0031350
pharyngitis